DYN DYNE THERAPEUTICS INC
2026Q1 · CUSIP 26818M108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
227
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
114
Δ whales
-2
Inst. holding value
$3.3B
New positions
42
Closed positions
47
Price momentum (1Q)
+8.2%
Put / Call
4/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 10% | -33.2% | -69.6% |
| 2024Q1 | Top 5% | +66.6% | +2.6% |
| 2023Q1 | Top 14% | -23.9% | -19.8% |
| 2022Q3 | Top 11% | +34.7% | +40.1% |
Options Sentiment
Put holders
4
QoQ: -1
Call holders
3
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.15
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-52.2%
Debt ratio
19.9%
FCF (TTM)
-$443M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.